Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros












Intervalo de año de publicación
1.
Rev Alerg Mex ; 71(1): 76, 2024 Feb 01.
Artículo en Español | MEDLINE | ID: mdl-38683093

RESUMEN

OBJECTIVE: To relate the topical use of cannabis as an analgesic therapeutic alternative in patients with some inflammatory diseases in Salud Social I.P.S during May to July 2023. METHODS: An analytical, retrospective study was carried out. The population from which the sample was obtained corresponds to patients diagnosed with Arthrosis, Unspecified, Non-Toxic Multinodular Goiter, Epilepsy, Unspecified Type Venous Insufficiency (Chronic) (Peripheral), Unspecified Lumbago, Secondary Gonarthrosis, Rotator Cuff Syndrome, Carpal Tunnel Syndrome, in Salud Social I.P.S of Barranquilla, Atlántico. A sample of 23 patients diagnosed with these pathologies was obtained by non-probabilistic convenience sampling. RESULTS: All patients showed pain relief after two months of follow-up, two experienced adverse effects. Some studies suggest that cannabinoids present in cannabis, such as CBD and THC, may have analgesic and anti-inflammatory properties that could alleviate pain and inflammation associated with these conditions. This is consistent with the present study. CONCLUSION: Topical cannabis is presented as a therapeutic alternative in inflammatory diseases, however, it is important to highlight that research on the use of cannabis in these diseases is limited and more studies are needed to fully understand its effects and potential benefits.


OBJETIVO: Relacionar el uso tópico de cannabis como alternativa terapéutica analgésica en pacientes con algunas enfermedades inflamatorias, de la IPS Salud Social, entre mayo y julio de 2023. MÉTODOS: Se realizó un estudio analítico, retrospectivo. La población de donde se obtuvo la muestra, corresponde a pacientes diagnosticados con Artrosis no especificada, bocio multinodular no tóxico, Epilepsia tipo no especificado, insuficiencia venosa crónica y periférica, Lumbago no especificado, gonartrosis secundaria, síndrome de manguito rotador, síndrome del túnel carpiano, de la IPS Salud Social de Barranquilla, Atlántico. Se obtuvo una muestra de 23 pacientes diagnosticados con estas patologías mediante muestreo no probabilístico por conveniencia. RESULTADOS: Todos los pacientes mostraron alivio del dolor, después de dos meses de seguimiento; dos experimentaron efectos adversos. Algunos estudios sugieren que los cannabinoides presentes en el cannabis, como el CBD y el THC, podrían tener propiedades analgésicas y antiinflamatorias que podrían aliviar el dolor y la inflamación asociados con estas afecciones, lo que es coherente con el presente estudio. CONCLUSIÓN: El cannabis tópico se presenta como una alternativa terapéutica para enfermedades inflamatorias, sin embargo, es importante destacar que la investigación sobre el uso del cannabis en estas enfermedades es limitada y se necesitan más estudios para comprender completamente sus efectos y beneficios potenciales.


Asunto(s)
Inflamación , Humanos , Estudios Retrospectivos , Masculino , Colombia , Femenino , Persona de Mediana Edad , Adulto , Inflamación/tratamiento farmacológico , Anciano , Analgésicos/uso terapéutico , Analgésicos/administración & dosificación , Administración Tópica , Marihuana Medicinal/uso terapéutico , Marihuana Medicinal/administración & dosificación
2.
Rev. cuba. salud pública ; Rev. cuba. salud pública;47(2): e2101, 2021. tab, graf
Artículo en Español | LILACS, CUMED | ID: biblio-1341492

RESUMEN

Introducción: En el departamento del Atlántico los estudios de resistencia del Mycobacterium tuberculosis se han limitado a drogas de segunda línea. Objetivo: Determinar prevalencia de resistencia a amikacina, kanamicina, capreomicina y ofloxacina en casos de tuberculosis resistente a isoniacida, rifampicina o a ambas drogas, en el periodo 2013 a 2016 en el departamento del Atlántico. Métodos: Estudio transversal de 194 aislamientos resistentes a isoniacida, rifampicina o ambas, por metodología Genotype MTBDR plus versión 2, enviados al Instituto Nacional de Salud en el periodo 2013 al 2016 para ser confirmados y procesados para drogas de segunda línea. La proporción de resistencia, se hizo según variables sociodemográficas, clínica y de vigilancia en salud pública. Resultados: Las comorbilidades frecuentes encontradas fueron desnutrición con el 18,56 por ciento, seguido de infección concomitante VIH-tuberculosis con el 13,40 por ciento. La ofloxacina en casos no tratados obtuvo la mayor resistencia global con el 1,50 por ciento (IC 95 por ciento 0,18-5,33). En los que fueron previamente tratados la resistencia global a capreomicina fue del 8,10 por ciento (IC 95 por ciento 2,7-17,8). En los resistentes a rifampicina, un caso fue extensivamente resistente y dos casos resistentes en los multidrogorresistente. Conclusiones: Se encontró baja resistencia a fluoroquinolonas y fármacos inyectables en pacientes no tratados resistentes a isoniacida, rifampicina o ambas, que muestra que todavía no constituye un problema mayor en el departamento del Atlántico. Se debe complementar su seguimiento con buen manejo tanto físico como psicológico y un equipo de salud fortalecido que actúe prontamente y ayude a la adherencia del paciente a los tratamientos(AU)


Introduction: In Atlántico department, resistance studies of Mycobacterium tuberculosis have been limited to second-line drugs. Objective: Determine prevalence of resistance to amikacin, kanamycin, capreomycin and ofloxacin in cases of tuberculosis resistant to isoniazid, rifampicin or both, in the period 2013 to 2016 in Atlántico department. Methods: Cross-sectional study of 194 isolations resistant to isoniazid, rifampicin or both, by Genotype MTBDR plus version 2 methodology, that were sent to the National Institute of Health from 2013 to 2016 to be confirmed and processed for second-line drugs. The resistance ratio was made according to sociodemographic, clinical and public health surveillance variables. Results: The common comorbilities found were malnutrition with 18.56 percent, followed by concomitant HIV-tuberculosis infection with 13.40 percent. Ofloxacin in non-treated cases achieved the highest overall resistance with 1.50 percent (95 percent CI 0.18-5.33). In those previously treated, global resistance to capreomycin was 8.10 percent (95 percent CI 2.7-17.8). In the ones resistant to rifampicin, one case was extensively resistant and two cases were resistant in multi-drugs resistant. Conclusions: Low resistance to fluoroquinolones and injectable drugs was found in non-treated patients who were resistant to isoniazid, rifampicin or both, showing that it is not yet a major problem in Atlántico department. Its follow-up should be complemented with good physical and psychological management and a strengthened health team that acts promptly and helps the patient adherence to treatments(AU)


Asunto(s)
Humanos , Rifampin/uso terapéutico , Tuberculosis Resistente a Múltiples Medicamentos , Fluoroquinolonas/antagonistas & inhibidores , Isoniazida/uso terapéutico , Estudios Transversales
3.
Mol Biol Rep ; 40(7): 4257-67, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23666052

RESUMEN

Amerindian Mapuche (Araucanians) are now living in Chile and Argentina at both sides of Andean Mountains. They are anthropologically and genetically different from southernmost South America Patagonian Amerindians. Most of the HLA alleles found in our Mapuche sample are frequent or very frequent in North and South America Amerindians: (1) Class I: A*02:01, A*03:01, A*68:01, B*39:09, B*51:01, (2) Class II: DRB1*03:01, DRB1*04:03, DRB1*07:01, DRB1*08:02, DRB1*14:02, DRB1*16:02. One of the nine most frequent extended haplotypes seems to be from European origin, suggesting the existence of a degree of admixture with Europeans in our Mapuche sample. It has been calculated of about 11 % admixture. Three of the extended haplotypes are also found in other Amerindians and five of them are newly found in Mapuche Amerindians: A*68:01-B*39:09-DRB1*08:02-DQB1*04:02; A*68:01-B*51:01-DRB1*04:03-DQB1*03:02; A*29:01-B*08:01-DRB1*03:01-DQB1*02:01; A*02:01-B*15:01-DRB1*04:03-DQB1*03:02; A*33:01-B*14:02-DRB1*07:01-DQB1*03:03. The medical importance of calculating HLA profile is discussed on the diagnostic (HLA and disease) and therapeutical bases of HLA pharmacogenomics and on the construction of a virtual transplantation HLA list profile. Also, anthropological conclusions are drawn.


Asunto(s)
Antígenos HLA/genética , Indígenas Sudamericanos/genética , Alelos , Argentina , Chile , Evolución Molecular , Frecuencia de los Genes , Variación Genética , Haplotipos , Humanos , Filogenia , Filogeografía
4.
Biosalud ; 11(1): 34-38, ene.-jun. 2012. ilus
Artículo en Español | LILACS | ID: lil-656877

RESUMEN

Introducción: determinar los niveles de eosinófilos, linfocitos y neutrófilos producidos con una infusión de la planta medicinal Bursera sp. Materiales y métodos: se seleccionaron cinco individuos sanos. Se determinaron porcentajes de células blancas iniciales por hemoleucograma. Luego se les suministró una toma diaria de 5 g de la corteza del árbol Bursera sp, previo consentimiento informado. Posteriormente, se les realizó hemoleucograma a los 17 días (primer muestreo) y a los 31 días (segundo muestreo). Resultados: en la mayoría de los casos se cumple que al umentar los eosinófilos y los neutrófilos, los linfocitos permanecen bajos. Discusión: estos resultados pueden indicar un efecto inmunomodulador de la infusión de la planta Bursera sp, especialmente sobre los linfocitos, mostrando a esta planta como una alternativa terapéutica para la inmunología de los trasplantes y en enfermedades autoinmunitarias, ya que se apreció una disminución de linfocitos cuando los neutrófilos y eosinófilos aumentaron; debido a la muestra pequeña así como a la adherencia incompleta de algunos de los individuos del estudio, es pertinente realizar estudios con una mayor muestra y con análisis adicionales, como inmunoglobulinas séricas y citometría de flujo, para determinar si la disminución de los linfocitos afectó a los Linfocitos T, B o ambos.


Introduction: to determine the levels of eosinophils, lymphocytes and neutrophils produced with the Bursera sp. medicinal plant infusion Materials and methods: five healthy individuals were selected. Initially, white cells percentages were determined by cell blood count. Then, previous informed consent, hey were given a daily intake of 5 g of Bursera sp tree bark. Subsequently, cell blood count was performed after 17 days (first sampling) and after 31 days (second sampling). Results: in most cases the increase in eosinophils and neutrophils, lymphocytes remained low. Discussion: these results may indicate an immunomodulatory effect of Bursera sp infusion especially on lymphocytes, showing this plant as a therapeutic alternative for transplant immunology and in autoimmune diseases since a decrease in lymphocytes was noticed when neutrophils and eosinophils increased. Due to the small sample and incomplete adherence to some of the individuals in the study, it is relevant to carry out studies with a larger sample and additional analysis such as serum immunoglobulins and flow cytometry to determine whether the decrease of lymphocytes affected the T lymphocytes, the B ones or both.

5.
Mol Biol Rep ; 39(4): 4875-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22081205

RESUMEN

Metabolic syndrome (MS) and obesity are principal causes of morbidity all over the World, particularly for their association to cardiovascular risk. Amerindians are often living in countries and remote areas with unavailable sophisticated diagnoses methodologies. However, waist-circumference is a reliable and easy to record parameter of visceral obesity and MS. Waist circumference normal values are not yet established in Amerindians: South Asian and Japanese values have been recommended for Amerindian use. The purpose of this study is to objectively define for the first time the waist circumference measure cut-off points for Amerindians. A total of 303 unrelated Amerindian adults recently immigrated to Madrid were studied; they were healthy, since they were questioned and tested as appropriate for blood donation. Waist-circumference was measured in these voluntary blood donors after written consent. Chosen subjects for study had HLA quasi-specific Amerindian genes and not gained weight since their relatively short time living in Spain. Amerindians with Type I or II diabetes or family antecedents were removed from the study. The biochemical parameter used to define normality for MS was the reliable serum HDL-cholesterol levels, whose values are diet independent. A Receiver Operating Characteristic analysis was used to compare the predictive validity and to find out the optimal cut-off points of waist circumference normal values. Cut-off points were ≤88.5 cm in males and ≤82.5 cm in females; these values were close to the median values (88 and 82.2 cm, respectively). Obtained waist circumference values recorded here in normal Amerindians are different to those previously recommended indirectly (those of South Asian/Japanese populations). These parameters may be of great value for American countries health care in order to predict and control MS and its cardiovascular complications. Other countries having a heavy Amerindian immigration (i.e.: USA, Spain) may also benefit for establishing specific Preventive Medicine programs.


Asunto(s)
Antígenos HLA/inmunología , Indígenas Sudamericanos , Obesidad/diagnóstico , Obesidad/inmunología , Circunferencia de la Cintura/inmunología , Adulto , Femenino , Salud , Humanos , Masculino , Curva ROC , Estándares de Referencia , España
6.
Mol Biol Rep ; 39(2): 1387-94, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21633894

RESUMEN

Conquest of Granada Muslim Kingdom (1492 AD) finished with Muslim occupation; they were mostly North African Berbers who had reached Iberia by 711 AD. A politics of Iberian Christianization followed after this date: Jewish were expelled in 1492 and Moriscos (Spaniards practicing Muslim religion or speaking Arab) were expelled from all Spanish territory on 1609 AD. Las Alpujarras is a southern Spain mountainous secluded region, which underwent a repopulation from North Spain and a specific Muslim (Moriscos)-Christian war took place according to historical records. Both Las Alpujarras repopulation by northern Iberians and Moriscos expulsion success have been debated and are regarded as non-clarified episodes. In this study, we have addressed the question whether the repopulation succeeded by determining HLA genes of present day Las Alpujarras inhabitants and compared with those of other Mediterranean populations HLA frequencies and genealogies. HLA frequencies show ambiguous results because of extant HLA similar gene frequencies there exist in North Africa and Spain. This is reflected by the finding of North and South western Mediterraneans close relatedness of HLA dendrograms and correspondence analyses. However, the genealogical study of extended HLA haplotypes particularly Alpujarran high frequency of HLA-A29-B44-DRB1*0701-DQA1*02-DQB1*02 (not found in Algerians but frequent in North and Central Spain) and Alpujarran low frequency extended haplotype HLA-A3-B7-DRB1*1501-DQA1*0102-DQB1*0602 (frequent in North Europe) reveals that a significant HLA gene flow from North Spain is observed in present day Alpujarrans: both haplotypes are characteristic of North Spain and North Europe, respectively. This may indicate that enforced Alpujarran repopulation from North Spain may have been a success, which was started by Spanish King Philip II in 1571 AD.


Asunto(s)
Emigración e Inmigración/historia , Etnicidad/genética , Genética de Población/métodos , Antígenos HLA/genética , Dinámica Poblacional/historia , Secuencia de Bases , Análisis por Conglomerados , Femenino , Frecuencia de los Genes , Genotipo , Haplotipos/genética , Historia del Siglo XVI , Humanos , Masculino , Datos de Secuencia Molecular , Análisis de Secuencia de ADN , España
7.
Mol Biol Rep ; 38(4): 2263-71, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20931290

RESUMEN

Amerindians immigrated to Madrid (Spain) region are about 10% of the present day population. Amerindians are believed to be the first American inhabitants, before Na-Dene speakers, Aleuts and Eskimo. They may initially have arrived to America from Siberia and also from other parts of Pacific Sea (South Asia, Polynesia and Australia). Nowadays, they populate America from Canada to Tierra del Fuego (South America tip South). Most Amerindian immigrants to Madrid have come from Andean Countries in the last 10 years (mainly Ecuador, Bolivia, Peru and Colombia). They show an HLA profile with "quasi-specific alleles", which makes them different to the rest of the World. In the present work, we have aimed to determine the immigrants HLA profile in order to establish a virtual transplantation waiting list which may be useful for their therapeutic transplants, particularly bone marrow transplantation. This would be carried out together with Amerindian immigrants to other parts of Spain and with their own countries in order to build up transplantation programs. Specific epidemiology programs on HLA linked disease will also be established. Immigrant volunteer unrelated blood donors contributed to the present study. HLA typing was performed by standard methods and their HLA profile obtained and obtained and compared with 15,108 HLA chromosomes from the rest of the World, including Spaniards. The immigrants showed a typical Amerindian profile similar to isolated Amerindian ethnic groups and altogether different to other World inhabitants (including Spaniards). These are the first bases to set up transplantation and epidemiology studies in collaboration with their original population in America. Finally, the HLA profile found in these Amerindians does not indicate their American specific original area, as it is expected from previous studies, i.e.: they do not relate more with Andean than with other Amerindians in Neighbour Joining dendrograms or correspondence analyses.


Asunto(s)
Factores Epidemiológicos , Genética de Población , Antígenos HLA/genética , Trasplante de Médula Ósea , Análisis por Conglomerados , Frecuencia de los Genes , Genotipo , Haplotipos/genética , Humanos , Indígenas Sudamericanos/etnología , Internet , Desequilibrio de Ligamiento , Filogenia , España/epidemiología , Listas de Espera
8.
Genet Test Mol Biomarkers ; 15(1-2): 97-102, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21189067

RESUMEN

BACKGROUND: The major histocompatibility complex genes are located on the short arm of the human sixth chromosome; they are highly polymorphic and therefore have been very advantageous in population genetic studies. METHODS: A Mazahua group established in North Mexico State and also in nearby Michoacan state in the rainy mountain highlands (Mexico) was studied for their human leukocyte antigen (HLA)-DRB1 alleles. The relationship with other Amerindians and worldwide populations was studied by using 14,996 chromosomes from 75 different populations and calculating neighbor-joining dendrograms and correspondence multidimensional values. RESULTS: Five principal HLA allele frequencies were found in our group: DRB1*0802 (the most frequent one in this population), DRB1*0407, DRB1*0403, DRB1*0101, and DRB1*1406. Both genetic distances and correspondence analyses clearly show that our Mazahua group is genetically close to some of the most ancient groups living in Mexico (Mayos, Zapotecans, Tennek) and South American Amerindians. Amerindians remain as a group apart from the rest of the world. CONCLUSIONS: The results analyzing the HLA-DR locus suggest that Mazahua language (Otomangue) does not correlate with those of the most closely HLA-correlated ethnic groups. The present data may be useful for future transplantation programs, HLA and disease diagnosis, and pharmacogenetic studies.


Asunto(s)
Genes MHC Clase II/genética , Antígenos HLA-DR/genética , Lenguaje , Haplotipos , Humanos , México/etnología , Grupos de Población/genética
9.
Immunol Invest ; 40(1): 92-100, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-20923327

RESUMEN

Amerindians origins and prehistory are still debated. HLA profile is different to all other World populations, although they have particular alleles in common with Asians, Australians and Pacific Islanders. In the present work, HLA-A, -B, -DRB1, -DQB1 alleles have been studied in Wayu Amerindians from Colombia. HLA alleles haplotypes, genetic distances and NJ dendrograms were calculated by Arlequin and DISPAN software. Only a few both class I and class II alleles have been observed. Most common extended haplotypes include: A*24-B*51-DRB1*0403-DQB1*0302, A*2-B*15-DRB1*1602-DQB1*0301, A*2-B*35-DRB1*0407-DQB1*0302, but also A*68-B*15-DRB1*0403-DQB1*0302. No trace of Caucasoid or Negroid admixture is detected. The Wayu HLA profile is typical from Amerindians and shows how languages and genes do not correlated particularly in this case (i.e., Wayu closest HLA genetic group is North Argentinian Guarani group). Results obtained in this work may be useful for future transplant programs and also for HLA linked diseases and individualized pharmacogenetics.


Asunto(s)
Antígenos HLA-A/genética , Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Indígenas Sudamericanos/genética , Alelos , Colombia/etnología , Frecuencia de los Genes , Antígenos HLA-B/genética , Cadenas HLA-DRB1 , Haplotipos/genética , Humanos , Linaje
10.
Hum Biol ; 82(5-6): 737-44, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21417892

RESUMEN

We typed a subset of the Aleut population for HLA loci (HLA-A, HLA-B, HLA-DRB1, HLA-DQB1) to obtain an HLA profile, which was compared to other Eurasian and Amerindian populations for studying Aleut origin and its significance on the peopling of the Americas. Allele frequencies at the four loci were identified in an Aleut sample using standard indirect DNA sequencing methods. Genetic distances with Amerindians and Eurasians were obtained by comparing Aleut allele frequencies with a worldwide population database (13,164 chromosomes). The most frequently extended HLA haplotypes were also calculated. We also generated Aleut relatedness dendrograms and calculated correspondence relatedness in a multidimensional scale. Both neighbor-joining dendrograms and correspondence analysis separated Aleuts from Eskimos and Amerindians. Aleuts are closer genetically to Europeans, including Scandinavians and English. Our results are concordant with those obtained by Y-chromosome analysis, suggesting that most male Aleut ancestors of our sample came mainly from Europe.


Asunto(s)
Antígenos HLA-A/genética , Antígenos HLA-B/genética , Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Inuk/genética , Alaska , Europa (Continente) , Cadenas beta de HLA-DQ , Cadenas HLA-DRB1 , Historia Antigua , Humanos , Indígenas Norteamericanos/genética , Indígenas Norteamericanos/historia , Indígenas Norteamericanos/estadística & datos numéricos , Inuk/historia , Inuk/estadística & datos numéricos , Masculino , Filogeografía/historia , Federación de Rusia , Población Blanca
11.
Hum Immunol ; 70(12): 1035-40, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19651181

RESUMEN

Major histocompatibility complex (MHC)-G and -C molecules bear ligands to natural killer immunoglobulin receptors (KIR). MHC-G evolution in primates shows some anomalies. In New World monkeys MHC-G molecules show a high polymorphism and most likely are classical antigen presenters; they also cluster closer to MHC-E in a relatedness dendrogram. Their genes lack intron 2 deletion, which is typical of all other primates in regard to MHC-G. Medium-sized Eurasian-African monkeys (Cercopithecinae) show stop codons in exon 3: only MHC-G isoforms without exon 3 are possible. Big apes such as the orangutan, gorilla, and chimpanzee as well as human beings show limited HLA-G polymorphism. HLA-C has not been found in medium-size Eurasian-African monkeys, but we have found MHC-C DNA sequences in more evolutionary ancient New World monkeys. Taking into account that the KIR inhibitory receptors signal is dominated by MHC-C in human beings, this suggests that both MHC-C molecules and their ligands within natural killer lymphocyte KIR also exist in the most evolutionary ancient apes (New World monkeys were present on Earth before 40 million years ago), as KIR receptors also appeared before 130 million years ago in evolution. Indeed, KIR receptor genes have recently been found in a New World monkey.


Asunto(s)
Evolución Molecular , Antígenos HLA/genética , Antígenos HLA-C/genética , Antígenos de Histocompatibilidad Clase I/genética , Complejo Mayor de Histocompatibilidad/genética , Primates/inmunología , Animales , Secuencia de Bases , Antígenos HLA/química , Antígenos HLA-G , Antígenos de Histocompatibilidad Clase I/química , Humanos , Células Asesinas Naturales/inmunología , Datos de Secuencia Molecular , Filogenia , Primates/genética , Receptores KIR/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...